To the best of the authors’ knowledge, this is the first study to address the issue of behavioural disorders and sensory impairment in patients with HPMRS1, which proved to be frequent among this population and, as such, requires adequate therapeutic strategies. The gene discussed is PIGV; the disease is Somatic sensory dysfunction.